ZA919932B - A method of constructing synthetic leader sequences - Google Patents

A method of constructing synthetic leader sequences

Info

Publication number
ZA919932B
ZA919932B ZA919932A ZA919932A ZA919932B ZA 919932 B ZA919932 B ZA 919932B ZA 919932 A ZA919932 A ZA 919932A ZA 919932 A ZA919932 A ZA 919932A ZA 919932 B ZA919932 B ZA 919932B
Authority
ZA
South Africa
Prior art keywords
leader sequences
synthetic leader
constructing synthetic
constructing
sequences
Prior art date
Application number
ZA919932A
Other languages
English (en)
Inventor
Lars Christiansen
Christiansen Lars
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA919932B publication Critical patent/ZA919932B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
ZA919932A 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences ZA919932B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser

Publications (1)

Publication Number Publication Date
ZA919932B true ZA919932B (en) 1992-08-26

Family

ID=8118017

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919932A ZA919932B (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences

Country Status (17)

Country Link
EP (1) EP0563175A1 (fr)
JP (1) JPH06503957A (fr)
KR (1) KR930703450A (fr)
AU (1) AU660161B2 (fr)
CA (1) CA2098731A1 (fr)
CZ (1) CZ119293A3 (fr)
DK (1) DK300090D0 (fr)
FI (1) FI932831A (fr)
HU (1) HUT68751A (fr)
IE (1) IE914433A1 (fr)
IL (1) IL100408A0 (fr)
MX (1) MX9102684A (fr)
NZ (1) NZ241011A (fr)
PT (1) PT99848A (fr)
SK (1) SK62593A3 (fr)
WO (1) WO1992011378A1 (fr)
ZA (1) ZA919932B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
US5538863A (en) * 1993-07-01 1996-07-23 Immunex Corporation Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
US5639642A (en) * 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
IL114160A (en) * 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
NZ303162A (en) 1995-03-17 2000-01-28 Novo Nordisk As Enzyme preparations comprising an enzyme exhibiting endoglucanase activity appropriate for laundry compositions for textiles
BR9707807A (pt) 1996-03-01 1999-07-27 Novo Nordisk As Uso de uma composição farmacêutica composição farmacêutica processo de tratar doenças ou distúrbios associados com a regulação do apetite prejudicado e uso de um peptideo
DE69739319D1 (de) 1996-12-13 2009-04-30 Novartis Vaccines & Diagnostic Verfahren zur Expression von PDGF oder IGR Proteinen in Hefe
JP2003525570A (ja) 1998-01-23 2003-09-02 ノボ ノルディスク アクティーゼルスカブ 酵母において所望のポリペプチドを産生する方法
DE60044728D1 (de) 1999-12-29 2010-09-02 Novo Nordisk As VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE
AT410217B (de) * 2000-06-15 2003-03-25 Cistem Biotechnologies Gmbh Vektor und ein verfahren zur expression und selektion randomisierter peptid-sequenzen
ES2432967T3 (es) 2001-03-22 2013-12-05 Novo Nordisk Health Care Ag Derivados del Factor VII de coagulación
ATE532858T1 (de) 2001-09-27 2011-11-15 Novo Nordisk Healthcare Ag Menschliche gerinnungsfaktor-vii-polypeptide
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
JP2007532096A (ja) 2003-11-14 2007-11-15 ノボ　ノルディスク　アクティーゼルスカブ アシル化されたインスリンの製造方法
ES2369895T3 (es) 2003-12-03 2011-12-07 Novo Nordisk A/S Insulina monocatenaria.
WO2005078116A1 (fr) * 2004-01-16 2005-08-25 Qiuyun Liu Methode permettant d'isoler de peptides antibacteriens et peptides isoles
ES2357550T3 (es) 2005-04-18 2011-04-27 Novo Nordisk A/S Variantes de la il-21.
CN102660614A (zh) 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
US20090055942A1 (en) 2005-09-14 2009-02-26 Novo Nordisk Healthcare A/G Human Coagulation Factor VII Polypeptides
ATE482977T1 (de) 2006-02-27 2010-10-15 Novo Nordisk As Insulinderivate
EP2069502B1 (fr) 2006-09-27 2014-02-26 Novo Nordisk A/S Procédé de fabrication de polypeptides d'insuline mature
WO2009021955A1 (fr) 2007-08-13 2009-02-19 Novo Nordisk A/S Analogues de l'insuline à action rapide
ES2526924T3 (es) 2007-08-15 2015-01-16 Novo Nordisk A/S Insulinas con una fracción acilo que comprende unidades repetitivas de aminoácidos que contienen alquilenglicol
EP2178912B1 (fr) 2007-08-15 2015-07-08 Novo Nordisk A/S Analogues de l'insuline comprenant un fragment acyle et alkylène glycol
EP2406282A1 (fr) 2009-03-11 2012-01-18 Novo Nordisk A/S Variants de l'interleukine 21 se liant de manière antagoniste au récepteur de l'il-21
AU2010272483B2 (en) 2009-07-17 2016-07-21 Omeros Corporation MASP isoforms as inhibitors of complement activation
EP2504355B1 (fr) 2009-11-25 2015-07-22 Novo Nordisk A/S Procédé de fabrication de polypeptides
WO2011067283A1 (fr) 2009-12-01 2011-06-09 Novo Nordisk A/S Nouvelles peptidyl a-hydroxyglycine a-amide lyases
ES2543634T3 (es) 2010-01-22 2015-08-20 Novo Nordisk A/S Proceso para preparación de FGF-21 con grado de O-glicosilación bajo
JP6148013B2 (ja) 2010-03-05 2017-06-14 リグショスピタレト 補体活性化のキメラ抑制分子
AU2011282988A1 (en) * 2010-07-28 2013-01-31 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
US11787844B2 (en) 2012-02-09 2023-10-17 Var2 Pharmaceuticals Aps Targeting of chondroitin sulfate glycans
JP2015532307A (ja) 2012-10-15 2015-11-09 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 凝固因子ｖｉｉポリペプチド
EP3004156A1 (fr) 2013-06-07 2016-04-13 Novo Nordisk A/S Procédé de fabrication de polypeptides d'insuline mature
US20160376330A1 (en) * 2014-02-28 2016-12-29 Novo Nordisk A/S Mating factor alpha pro-peptide variants
CN112789504A (zh) 2018-07-13 2021-05-11 瓦克特诊断有限责任公司 使用重组疟疾蛋白var2csa分离胎儿来源的循环细胞

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
CA1340772C (fr) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression et secretion de proteines heterologues dans une levure au moyen de sequences leader tronquees du facteur alpha
JP3092811B2 (ja) * 1988-07-23 2000-09-25 デルタ バイオテクノロジー リミテッド ペプチドおよびｄｎａ配列
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
AU660161B2 (en) 1995-06-15
CZ119293A3 (en) 1994-02-16
FI932831A0 (fi) 1993-06-18
WO1992011378A1 (fr) 1992-07-09
CA2098731A1 (fr) 1992-06-19
PT99848A (pt) 1993-06-30
IE914433A1 (en) 1992-07-01
HUT68751A (en) 1995-07-28
NZ241011A (en) 1993-04-28
SK62593A3 (en) 1993-10-06
DK300090D0 (da) 1990-12-19
AU9134891A (en) 1992-07-22
MX9102684A (es) 1992-06-01
FI932831A (fi) 1993-06-18
EP0563175A1 (fr) 1993-10-06
IL100408A0 (en) 1992-09-06
JPH06503957A (ja) 1994-05-12
HU9301801D0 (en) 1993-10-28
KR930703450A (ko) 1993-11-30

Similar Documents

Publication Publication Date Title
ZA919932B (en) A method of constructing synthetic leader sequences
GB9024684D0 (en) A method of communicating data
PL296827A1 (en) Method of preparing a contrast medium
HK1000957A1 (en) Method of manufacturing a plastic cartridge
EP0445692A3 (en) A method of producing monoglyceride
EP0562696A3 (en) A method of making a synthetic seismogram
EP0448033A3 (en) Method of manufacturing a magnetic head
GB2277766B (en) Method of constructing a roadway
EP0543257A3 (en) Method of manufacturing a power-misfet
OA09821A (en) Method of cementing a well
GB9108272D0 (en) Method of constructing a roadway
EP0480313A3 (en) Method of fabrication a t-gate-electrode
GB2394222B (en) A method of making a polynitramine
PL290622A1 (en) Method of obtaining a dipeptyde compound
GB9024213D0 (en) Method of producing a colouring system
GB2262268B (en) A method of clothing manufacture
GB9004087D0 (en) A new method of amplification
PL290392A1 (en) Method of moulding a lintel
GB9018208D0 (en) A method of tube forming
PL286457A2 (en) Method of obtaining a collagen compound
PL287634A2 (en) Method of obtaining a chiral diazacoronand
PL290421A1 (en) Method of obtaining a biopreparation polagrocyna
GB9021467D0 (en) A method of forming a gaiter
ZA914891B (en) Method of constructing a foundation
PL284805A2 (en) Method of obtaining a cobaltized azo dye 1:2